The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shirinsky V.S.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia

Shirinsky I.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia

Chronic pain and multimorbidity

Authors:

Shirinsky V.S., Shirinsky I.V.

More about the authors

Journal: Russian Journal of Pain. 2026;24(1): 72‑81

Read: 773 times


To cite this article:

Shirinsky VS, Shirinsky IV. Chronic pain and multimorbidity. Russian Journal of Pain. 2026;24(1):72‑81. (In Russ.)
https://doi.org/10.17116/pain20262401172

Recommended articles:
Comparative evaluation of oral chondroprotectors effe­ctiveness in patients with low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):98-103
Myoadaptive overload syndromes of lower extremities in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):89-93
Musculoskeletal diso­rders in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):6-10

References:

  1. Kang Y, Trewern L, Jackman J, McCartney D, Soni A. Chronic pain: definitions and diagnosis. BMJ. 2023;381:e076036. https://doi.org/10.1136/bmj-2023-076036
  2. Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016;6:e010364. https://doi.org/10.1136/bmjopen-2015-010364
  3. Sá KN, Moreira L, Baptista AF. Prevalence of chronic pain in developing countries: systematic review and meta-analysis. Pain Rep. 2019;4:e779. https://doi.org/10.1097/PR9.0000000000000779
  4. Smith BH, Fors EA, Korwisi B, etalIASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: applicability in primary care. Pain. 2019 Jan;160(1):83-87. PMID: 30586075. https://doi.org/10.1097/j.pain.0000000000001360
  5. Gordon K, Rice H, Allcock N. Barriers to self-management of chronic pain in primary care: a qualitative focus group study. Br J Gen Pract. 2017 Mar;67(656):e209-e217. Epub 2016 Dec 19. PMID: 27993899; PMCID: PMC5325663. https://doi.org/10.3399/bjgp17X688825
  6. Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, Kramer E. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010 Apr 26;10:102. PMID: 20420681; PMCID: PMC2874550. https://doi.org/10.1186/1472-6963-10-102
  7. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019 Jan;160(1):19-27. PMID: 30586067. https://doi.org/10.1097/j.pain.0000000000001384
  8. Bofanova NS, Masaeva RR, Verbitskaya OS, Koldova TG, Yadrentseva UV. Chronic pain in the 11th revision of the International Classification of Diseases. Russian Journal of Pain. 2021;19(1):36-39. (In Russ.). https://doi.org/10.17116/pain20211901136
  9. Scherer M, Hansen H, Gensichen J, Mergenthal K, Riedel-Heller S, Weyerer S, Maier W, Fuchs A, Bickel H, Schön G, Wiese B, König HH, van den Bussche H, Schäfer I. Association between multimorbidity patterns and chronic pain in elderly primary care patients: a cross-sectional observational study. BMC Fam Pract. 2016;17:68.  https://doi.org/10.1186/s12875-016-0468-1
  10. Ferguson M, Svendrovski A, Katz J. Association Between Multimorbid Disease Patterns and Pain Outcomes Among a Complex Chronic Care Population in Canada. J Pain Res. 2020 Nov 20;13:3045-3057. PMID: 33244262. https://doi.org/10.2147/JPR.S269648
  11. Siebenhuener K, Eschmann E, Kienast A, Schneider D, Minder CE, Saller R, Zimmerli L, Blaser J, Battegay E, Holzer BM. Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions? PLoS One. 2017 Jan 03;12(1):e0168987. PMID: 28046033; PMCID: PMC5207693. https://doi.org/10.1371/journal.pone.0168987
  12. Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, Czachowski S, Munoz M, Argyriadou S, Claveria A, Le Floch B, Barais M, Bower P, Van Marwijk H, Van Royen P, Lietard C. The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013 May;14(5):319-325. Epub 2013 Feb 12. PMID: 23411065. https://doi.org/10.1016/j.jamda.2013.01.011
  13. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, Lara E, Koskinen S, Tobiasz-Adamczyk B, Ayuso-Mateos JL, Haro JM. Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study. J Gerontol A Biol Sci Med Sci. 2016 Feb;71(2):205-214. Epub 2015 Sept 29. PMID: 26419978; PMCID: PMC5864156. https://doi.org/10.1093/gerona/glv128
  14. Häuser W, Perrot S, Sommer C, Shir Y, Fitzcharles MA. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep. 2017 Apr 30;2(3):e598. PMID: 29392213; PMCID: PMC5741304. https://doi.org/10.1097/PR9.0000000000000598
  15. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavandʼhomme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27.  https://doi.org/10.1097/j.pain.0000000000001384
  16. Kang J-H, Choi S-E, Park D-J, Lee S-S. Disentangling Diagnosis and Management of Fibromyalgia. J Rheum Dis. 2022 Jan 01;29(1):4-13. PMID: 37476701; PMCID: PMC10324920. https://doi.org/10.4078/jrd.2022.29.1.4
  17. Bhargava J, Hurley JA. Fibromyalgia. 2023 June 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31082018.
  18. Sleurs D, Tebeka S, Scognamiglio C, Dubertret C, Le Strat Y. Comorbidities of self-reported fibromyalgia in United States adults: A cross-sectional study from The National Epidemiological Survey on Alcohol and Related Conditions (NESARC-III). Eur J Pain. 2020;24(8):1471-1483. https://doi.org/10.1002/ejp.1585
  19. Wolfe F, Ablin J, Guymer EK, Littlejohn GO, Rasker JJ. The Relation of Physical Comorbidity and Multimorbidity to Fibromyalgia, Widespread Pain, and Fibromyalgia-related Variables. J Rheumatol. 2020;47(4):624-631.  https://doi.org/10.3899/jrheum.190149
  20. Rivera FA, Munipalli B, Allman ME, Hodge DO, Wieczorek MA, Wang B, Abril A, Perlman A, Knight D, Bruce B. A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Front Med (Lausanne). 2024;10:1301944. https://doi.org/10.3389/fmed.2023.1301944
  21. Kleykamp BA, Ferguson MC, McNicol E, Bixho I, Arnold LM, Edwards RR, Fillingim R, Grol-Prokopczyk H, Turk DC, Dworkin RH. The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum. 2021;51(1):166-174.  https://doi.org/10.1016/j.semarthrit.2020.10.006
  22. Lichtenstein A, Tiosano S, Comaneshter D, Amital H, Cohen AD, Amital D. Cross-sectional analysis of the associations between fibromyalgia and diabetes mellitus. Reumatologia. 2018;56(5):275-278. Epub 2018 Oct 31. PMID: 30505007; PMCID:PMC6263302. https://doi.org/10.5114/reum.2018.79496
  23. Yakkaphan P, Smith JG, Chana P, Tan HL, Ravindranath PT, Lambru G, Renton T. Temporomandibular Disorders and Fibromyalgia Prevalence: A Systematic Review and Meta-Analysis. J Oral Facial Pain Headache. 2023 Nov 17;37(3):177-193. PMID: 37975782; PMCID: PMC10664703. https://doi.org/10.11607/ofph.3260
  24. D’Onghia M, Ciaffi J, Calabrese L, Tognetti L, Cinotti E, Rubegni P, Frediani B, Ursini F. Fibromyalgia and Skin Disorders: A Systematic Review. Journal of Clinical Medicine. 2024; 13(15):4404. https://doi.org/10.3390/jcm13154404
  25. Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol. 2018;30(1):94-100. PMID: 29040155. https://doi.org/10.1097/BOR.0000000000000464
  26. Littlejohn GO. Fibromyalgia and psoriatic arthritis: Partners together. Int J Rheum Dis. 2021 Feb;24(2):141-143. PMID: 33523565. https://doi.org/10.1111/1756-185X.14029
  27. Elsawy NA, Helal AH, Abd ElHamid HA, Abdel-Fattah YH. Fibromyalgia in patients with psoriatic arthritis: Impact on disease activity indices, fatigue and health-related quality of life. Int J Rheum Dis. 2021;24(2):189-196.  https://doi.org/10.1111/1756-185X.13987
  28. Ulutatar F, Unal-Ulutatar C, Tuncay Duruoz M. Fibromyalgia in patients with psoriatic arthritis: Relationship with enthesopathy, sleep, fatigue and quality of life. Int J Rheum Dis. 2021;24(2):183-188.  https://doi.org/10.1111/1756-185X.13963
  29. Mease PJ. Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol. 2017;29(4):304-310.  https://doi.org/10.1097/BOR.0000000000000388
  30. Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011;25(2):165-171.  https://doi.org/10.1016/j.berh.2010.01.011
  31. Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018;21(3):639-646.  https://doi.org/10.1111/1756-185X.13055
  32. Fitzcharles MA, Perrot S, Häuser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur J Pain. 2018;22(9):1565-1576. https://doi.org/10.1002/ejp.1252
  33. Zhuang J, Mei H, Fang F, Ma X. What Is New in Classification, Diagnosis and Management of Chronic Musculoskeletal Pain: A Narrative Review. Front Pain Res (Lausanne). 2022 July 15;3:937004. PMID: 35910265; PMCID: PMC9335004. https://doi.org/10.3389/fpain.2022.937004
  34. World Health Organization. International Classification of Diseases 11th Revision (ICD-11). Geneva: WHO; 2019. https://icd.who.int
  35. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M; Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367. https://doi.org/10.1016/S0140-6736(18)30480-X
  36. Olofsson H, Carlsson L, Bertilson BC. Multimorbidity among Patients with Back Pain: A Study of Records at a Swedish Primary Health Care Centre. J Family Med Prim Care Open Acc. 2018;2:118. 
  37. Marunica Karšaj J, Benjak T, Stojanović L, Grubišić F, Balen D, Grazio S. Chronic multimorbidity of low back pain or other chronic back disorders in the republic of croatia. Acta Clin Croat. 2023;62(1):141-152.  https://doi.org/10.20471/acc.2023.62.01.17
  38. Rafn BS, Hartvigsen J, Siersma V, Andersen JS. Multimorbidity in patients with low back pain in Danish chiropractic practice: a cohort study. Chiropr Man Therap. 2023 Feb 10;31(1):8. PMID: 36765327; PMCID: PMC9921470. https://doi.org/10.1186/s12998-023-00475-3
  39. Ferreira ÉMR, Lemes ÍR, Ribeiro EG, Malta DC, Maher CG, McAuley JH, Jones MD, Hespanhol L, Pinto RZ. Prevalence of non-communicable diseases, multimorbidity, and their impact on activity limitations among adults with chronic back pain: a national population-based study in a middle-income country. Braz J Phys Ther. 2025 Aug 02;29(5):101241.
  40. Hestbaek L, Leboeuf-Yde C, Kyvik KO. Is comorbidity in adolescence a predictor for adult low back pain? A prospective study of a young population. BMC Musculoskelet Disord. 2006;7:29.  https://doi.org/10.1186/1471-2474-7-29
  41. Looveren E, Mairesse O, Nijs J, Meeus M, Ickmans K, Cagnie B, Goubert D, Danneels L, Moens M, Malfliet A. Associates of Insomnia in People with Chronic Spinal Pain: A Systematic Review and Meta-Analysis. J Clin Med. 2021 July 19;10(14):3175. PMID: 34300341; PMCID: PMC8304652. https://doi.org/10.3390/jcm10143175
  42. Marunica Karšaj J, Grubišić F, Balen D, Jug J, Grazio S. Chronic non-specific low back pain disability and depressive symptoms in working men and women: a cross-sectional study. Rheumatol Int. 2024 Dec;44(12):2967-2975. Epub 2024 Sept 26. PMID: 39327275. https://doi.org/10.1007/s00296-024-05697-z
  43. Øverås CK, Johansson MS, de Campos TF, Ferreira ML, Natvig B, Mork PJ, Hartvigsen J. Distribution and prevalence of musculoskeletal pain co-occurring with persistent low back pain: a systematic review. BMC Musculoskelet Disord. 2021;22(1):91.  https://doi.org/10.1186/s12891-020-03893-z
  44. Øverås CK, Fernandez M, Boyle E, Hartvigsen J, Ferreira ML, Refshauge KM, Maher CG, Christensen K, Hopper JL, Ferreira PH. Is this back pain killing me? All-cause and cardiovascular-specific mortality in older Danish twins with spinal pain. Eur J Pain. 2017;21(5):938-948.  https://doi.org/10.1002/ejp.996
  45. Pinto EM, Neves JR, Laranjeira M, Reis J. The importance of inflammatory biomarkers in non-specific acute and chronic low back pain: a systematic review. Eur Spine J. 2023 Sept;32(9):3230-3244. https://doi.org/10.1007/s00586-023-07717-1
  46. Ma L, Zheng X, Lin R, Sun AR, Song J, Ye Z, Liang D, Zhang M, Tian J, Zhou X, Cui L, Liu Y, Liu Y. Knee Osteoarthritis Therapy: Recent Advances in Intra-Articular Drug Delivery Systems. Drug Des Devel Ther. 2022; 16:1311-1347. https://doi.org/10.2147/DDDT.S357386
  47. Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29-30:100587. PMID: 34505846; PMCID: PMC7704420. https://doi.org/10.1016/j.eclinm.2020.100587
  48. Englund M. Osteoarthritis, part of life or a curable disease? A bird’s-eye view. J Intern Med. 2023;293(6):681-693.  https://doi.org/10.1111/joim.13634
  49. Muckelt PE, Roos EM, Stokes M, McDonough S, Grønne DT, Ewings S, Skou ST. Comorbidities and their link with individual health status: A cross-sectional analysis of 23,892 people with knee and hip osteoarthritis from primary care. J Comorb. 2020; 10:2235042X20920456. https://doi.org/10.1177/2235042X20920456
  50. Moon P, Maddocks H, Freeman TR. Knee pain, with or without osteoarthritis, is associated with significant co-morbidity in a primary care population. Osteoarthritis and Cartilage. 2019;27:S278. ISSN: 1063-4584. https://doi.org/10.1016/j.joca.2019.02.659
  51. Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care Res. 2020;72:991-1000. https://doi.org/10.1002/acr.24008
  52. Swain S, Coupland C, Strauss V, Mallen C, Kuo CF, Sarmanova A, Bierma-Zeinstra SMA, Englund M, Prieto-Alhambra D, Doherty M, Zhang W. Clustering of comorbidities and associated outcomes in people with osteoarthritis — A UK Clinical Practice Research Datalink study. Osteoarthritis Cartilage. 2022 May;30(5):702-713. Epub 2022 Feb 02. PMID: 35122943. https://doi.org/10.1016/j.joca.2021.12.013
  53. Pineda-Moncusí M, Dernie F, Dell’Isola A, Kamps A, Runhaar J, Swain S, Zhang W, Englund M, Pitsillidou I, Strauss VY, Robinson DE, Prieto-Alhambra D, Khalid S. Classification of patients with osteoarthritis through clusters of comorbidities using 633 330 individuals from Spain. Rheumatology (Oxford). 2023 Nov 02;62(11):3592-3600. PMID: 36688706; PMCID: PMC10629784. https://doi.org/10.1093/rheumatology/kead038
  54. Zemedikun DT, Lee H, Nirantharakumar K, Raza K, Chandan JS, Lord JM, Jackson TA. Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis. Arthritis Res Ther. 2022 Oct 13; 24(1):231. PMID: 36229868; PMCID: PMC9559033. https://doi.org/10.1186/s13075-022-02909-4
  55. Kiadaliri A, Englund M. Osteoarthritis and risk of hospitalization for ambulatory care-sensitive conditions: A general population-based cohort study. Rheumatology (Oxford). 2021;60(9):4340-4347. https://doi.org/10.1093/rheumatology/keab161
  56. Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018;47(6):805-813.  https://doi.org/10.1016/j.semarthrit.2017.10.016
  57. Constantino de Campos G, Mundi R, Whittington C, Toutounji MJ, Ngai W, Sheehan B. Osteoarthritis, mobility-related comorbidities and mortality: An overview of meta-analyses. Ther Adv Musculoskelet Dis. 2020; 12:1759720X20981219. https://doi.org/10.1177/1759720X20981219
  58. Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018;47(5):1687-1704. https://doi.org/10.1093/ije/dyy134
  59. de Rooij M, van der Leeden M, Heymans MW, Holla JF, Häkkinen A, Lems WF. Prognosis of pain and physical functioning in patients with knee osteoarthritis: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2016;68(4):481-492.  https://doi.org/10.1002/acr.22693
  60. Raud B, Gay C, Guiguet-Auclair C, Bonnin A, Gerbaud L, Pereira B, Duclos M, Boirie Y, Coudeyre E. Level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Sci Rep. 2020 Feb 27;10(1):3601. PMID: 32107449; PMCID: PMC7046749. https://doi.org/10.1038/s41598-020-60587-1
  61. Holliday KL, McWilliams DF, Maciewicz RA, Muir KR, Zhang W, Doherty M. Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control study. Osteoarthritis Cartilage. 2011;19(1):37-43.  https://doi.org/10.1016/j.joca.2010.10.014
  62. King LK, March L, Anandacoomarasamy A. Obesity & osteoarthritis. Indian J Med Res. 2013;138(2):185-193. PMID: 24056594; PMCID: PMC3788203.
  63. Mulugeta A, Eshetie TC, Kassie GM, Erku D, Mekonnen A, Lumsden A, Hyppönen E. Association Between Metabolically Different Adiposity Subtypes and Osteoarthritis: A Mendelian Randomization Study. Arthritis Care Res. 2023;75:885-892.  https://doi.org/10.1002/acr.24884
  64. Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med. 2009;121(6):9-20.  https://doi.org/10.3810/pgm.2009.11.2073
  65. Zhang S, Wang D, Zhao J, Zhao H, Xie P, Zheng L, Sheng P, Yuan J, Xia B, Wei F, Zhang Z. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study. BMC Public Health. 2024 Jan 19;24(1):233. PMID: 38243159; PMCID: PMC10799367. https://doi.org/10.1186/s12889-024-17682-z
  66. Riddle DL, Stratford PW. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: a cohort study. Arthritis Care Res (Hoboken). 2013;65(1):15-22. PMID: 22505346; PMCID: PMC3401342. https://doi.org/10.1002/acr.21692
  67. Bliddal H, Leeds AR. Christensen, R. Osteoarthritis, obesity and weight loss. Obes Rev. 2014;15:578-586.  https://doi.org/10.1111/obr.12173
  68. Shirinsky VS, Kalinovskaya NYu, Filatova KYu, Shirinsky IV. Clinical and immunological features of metabolic phenotype of osteoarthritis. Medical Immunology (Russia). 2020;22(2):327-334. (In Russ.). https://doi.org/10.15789/1563-0625-CAI-1881
  69. Alekseeva LI, Sharapova EP, Lila AM. Osteoarthritis of hand joints: prevalence, risk factors, phenotypes, diagnosis, treatment. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2022;16(6):98-105. (In Russ.). https://doi.org/10.14412/1996-7012-2022-6-98-105
  70. Mulrooney E, Neogi T, Dagfinrud H, Hammer HB, Pettersen PS, Gløersen M, Kvien TK, Magnusson K, Haugen IK. Comorbidities in people with hand OA and their associations with pain severity and sensitization: Data from the longitudinal Nor-Hand study. Osteoarthr Cartil Open. 2023;5(3): 100367. https://doi.org/10.1016/j.ocarto.2023.100367
  71. Scherzer ZA, Alvarez C, Renner JB, Murphy LB, Schwartz TA, Jordan JM, Golightly YM, Nelson AE. Effects of Comorbid Cardiovascular Disease and Diabetes on Hand Osteoarthritis, Pain, and Functional State Transitions: The Johnston County Osteoarthritis Project. The Journal of Rheumatology. 2020;47(10):1541-1549. https://doi.org/10.3899/jrheum.191075
  72. Muthu S. Osteoarthritis, an old wine in a new bottle! World J Orthop. 2023; 14(1):1-5  https://doi.org/10.5312/wjo.v14.i1.1
  73. Galushko EA, Nasonov EL. Prevalence of rheumatic diseases in Russia. Almanac of Clinical Medicine. 2018;46(1):32-39. (In Russ.). https://doi.org/10.18786/2072-0505-2018-46-1-32-39
  74. Katz J, Bartels CM. Multimorbidity in Rheumatoid Arthritis: Literature Review and Future Directions. Curr Rheumatol Rep. 2024;26:24-35.  https://doi.org/10.1007/s11926-023-01121-w
  75. Dutt S, Roul P, Yang Y, Johnson TM, Michaud K, Sauer B, Cannon GW, Baker JF, Curtis JR, Mikuls TR, England BR. Multimorbidity Patterns and Rheumatoid Arthritis Disease Outcomes: Findings From a Multicenter, Prospective Cohort. Arthritis Care Res (Hoboken). 2023;2:10.1002/acr.25184. https://doi.org/10.1002/acr.25184
  76. England BR, Roul P, Yang Y, Sayles H, Yu F, Michaud K, Xie F, Curtis JR, Mikuls TR. Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015. Ann Rheum Dis. 2021;80(3):286-292.  https://doi.org/10.1136/annrheumdis-2020-218282
  77. England BR, Yang Y, Roul P, Haas C, Najjar L, Sayles H, Yu F, Sauer BC, Baker JF, Xie F, Michaud K, Curtis JR, Mikuls TR. Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning. Arthritis Care Res (Hoboken). 2023;75(2):220-230.  https://doi.org/10.1002/acr.24956
  78. England BR. The Multimorbidity Web in rheumatoid arthritis. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI242-SI251. PMID: 37871922. https://doi.org/10.1093/rheumatology/kead246
  79. Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Primers. 2022 July 14; 8(1):48. PMID: 35835758; PMCID: PMC7613517. https://doi.org/10.1038/s41572-022-00376-4
  80. Kovačević I, Pavić J, Filipović B, Ozimec Vulinec Š, Ilić B, Petek D. Integrated Approach to Chronic Pain — The Role of Psychosocial Factors and Multidisciplinary Treatment: A Narrative Review. Int J Environ Res Public Health. 2024;21:1135. https://doi.org/10.3390/ijerph21091135
  81. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273-e283. https://doi.org/10.1016/j.bja.2019.03.023
  82. Maly A, Vallerand AH. Neighborhood, Socioeconomic, and Racial Influence on Chronic Pain. Pain Manag Nurs. 2018 Feb;19(1):14-22. PMID: 29422123; PMCID: PMC8895435. https://doi.org/10.1016/j.pmn.2017.11.004
  83. Jordan KP, Thomas E, Peat G, Wilkie R, Croft P. Social risks for disabling pain in older people: a prospective study of individual and area characteristics. Pain. 2008;137(3):652-661.  https://doi.org/10.1016/j.pain.2008.02.030
  84. de Oliveira AMB, da Cruz Teixeira DS, dos Santos Menezes F, Marques AP, de Oliveira Duarte YA, Casarotto RA. Socioeconomic and sex inequalities in chronic pain: A population-based cross-sectional study. PLoS One. 2023;18(5):e0285975. https://doi.org/10.1371/journal.pone.0285975
  85. Prego-Domínguez J, Khazaeipour Z, Mallah N, Takkouche B. Socioeconomic status and occurrence of chronic pain: a meta-analysis. Rheumatology (Oxford). 2021 Mar 02;60(3):1091-1105. PMID: 33276382. https://doi.org/10.1093/rheumatology/keaa758
  86. Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018;42(2):186-194. Epub 2018 Feb 14. PMID: 29442409. https://doi.org/10.1111/1753-6405.12762
  87. Meints SM, Edwards RR. Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87 (Pt B):168-182. Epub 2018 Jan 31. PMID: 29408484; PMCID: PMC60679. https://doi.org/10.1016/j.pnpbp.2018.01.017
  88. Li M, She K, Zhu P, Li Z, Liu J, Luo F, Ye Y. Chronic Pain and Comorbid Emotional Disorders: Neural Circuitry and Neuroimmunity Pathways. International Journal of Molecular Sciences. 2025; 26(2):436.  https://doi.org/10.3390/ijms26020436
  89. Hayes C, Bruggink L, Rajappa H, Brain K, Pols M. A cumulative strain model for chronic pain and multimorbidity. Australian Journal of General Practice. 2025 Mar;54(3):129-133. PMID: 40043291. https://doi.org/10.31128/AJGP-02-24-7145
  90. Whitty CJM, MacEwen C, Goddard A, Alderson D, Marshall M, Calderwood C, Atherton F, McBride M, Atherton J, Stokes-Lampard H, Reid W, Powis S, Marx C. Rising to the challenge of multimorbidity. BMJ. 2020 Jan 06; 368:l6964. PMID: 31907164; PMCID: PMC7190283. https://doi.org/10.1136/bmj.l6964
  91. Puzyrev VP. Genetic bases of human comorbidity. Russian Journal of Genetics. 2015;51(4):408-417. (In Russ.). https://doi.org/10.1134/S1022795415040092
  92. Dong G, Feng J, Sun F, Chen J, Zhao XM. A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank. Genome Med. 2021;13(1):110.  https://doi.org/10.1186/s13073-021-00927-6
  93. Bevers K, Watts L, Kishino ND, Gatchel RJ. The Biopsychosocial Model of the Assessment, Prevention, and Treatment of Chronic Pain. US Neurology. 2016;12(2):98-104.  https://doi.org/10.17925/USN.2016.12.02.98
  94. Duffield SJ, Ellis BM, Goodson N, Walker-Bone K, Conaghan PG, Margham T, Loftis T. The contribution of musculoskeletal disorders in multimorbidity: Implications for practice and policy. Best Practice & Research: Clinical Rheumatology. 2017 Apr;31(2):129-144. Epub 2017 Nov 01. PMID: 29224692. https://doi.org/10.1016/j.berh.2017.09.004
  95. Schneider J, Algharably EAE, Budnick A, Wenzel A, Dräger D, Kreutz R. High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems. Front Pharmacol. 2021 June 08;12:686990. PMID: 34168565; PMCID: PMC8217758. https://doi.org/10.3389/fphar.2021.686990
  96. Woodman RJ, Koczwara B, Mangoni AA. Applying precision medicine principles to the management of multimorbidity: the utility of comorbidity networks, graph machine learning, and knowledge graphs. Frontiers in Medicine (Lausanne). 2024 Jan 24;10:1302844. PMID: 38404463; PMCID: PMC10885565. https://doi.org/10.3389/fmed.2023.1302844

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.